Table 2.
Number of CD8+ T cells, PD-L1+ cells, and PD-L1+CD8+ double-positive T cells in the spleen and tumor of each group (mean ± SD)
| Group | Spleen | Tumor | ||||
|---|---|---|---|---|---|---|
| CD8+ T cells | PD-L1+ cells | PD-L1+CD8+ T cells | CD8+ T cells | PD-L1+ cells | PD-L1+ CD8+ T cells | |
| C | 23.67 ± 6.66 | 23.00 ± 5.00 | 18.00 ± 3 0.00 | 30.00 ± 6.24 | 31.00 ± 6.56 | 26.33 ± 5.69 |
| wtT | 19.33 ± 6.70b | 20.00 ± 3.46 | 18.67 ± 4.16 | 27.00 ± 6.06b | 28.67 ± 6.66 | 24.33 ± 6.03c |
| shNT | 20.33 ± 3.37a | 21.00 ± 6.00 | 17.00 ± 2.65a | 20.67 ± 3.37a | 28.00 ± 4.00 | 19.67 ± 2.89a |
| shDT | 32.00 ± 8.29a | 29.00 ± 2.65b | 26.33 ± 3.79ab | 35.67 ± 9.91a | 35.67 ± 4.51b | 33.33 ± 3.79ab |
| oeNT | 22.33 ± 4.51 | 21.67 ± 4.16a | 20.00 ± 2.65 | 26.67 ± 7.8 | 29.00 ± 3.61a | 23.00 ± 2.65 |
| oeDT | 30.33 ± 4.97 | 14.33 ± 2.52abc | 14.00 ± 2.65bc | 32.67 ± 8.85 | 18.00 ± 3.46abc | 16.33 ± 4.04bd |
| wtT + PD-1 mAb | 35.33 ± 5.51 | 31.67 ± 6.51 | 30.00 ± 5.00 | 38.33 ± 6.99 | 39.67 ± 5.69 | 36.33 ± 7.57 |
| shDT + PD-1 mAb | 39.33 ± 10.74 | 34.00 ± 7.21 | 31.00 ± 5.29 | 46.00 ± 5.45 | 55.00 ± 9.00d | 45.00 ± 6.56e |
| oeDT + PD-1 mAb | 36.33 ± 4.20b | 26.67 ± 4.16c | 24.00 ± 7.21c | 41.00 ± 3.56b | 34.67 ± 4.62 cd | 33.00 ± 3.61cde |
The same superscript letter (e.g., a, b, c) indicates a significant difference between the groups (p < 0.05). Abbreviations: C: control; wtT: wild-type CD3+ T cells; shDT: CD3+ T cells with Drp1 knockdown; oeDT: CD3+ T cells with Drp1 overexpression; shNT and oeNT: negative control groups of T-shDrp1 and T-oeDrp1, respectively; PD-1 mAb: programmed cell death protein 1 monoclonal antibody; PBS: phosphate-buffered saline